l3,4,8,10K5L7

General Information


DRACP ID  DRACP00093

Peptide Name   l3,4,8,10K5L7

Sequence  KLllKLKlKlLK

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Diastereomeric peptide

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
B16-F10 Mouse melanoma Carcinoma LC50=100 µM XTT assay 24h 1
D122 Malignant tumors of the mouse pulmonary system Carcinoma LC50>50 µM XTT assay 24h 1

Hemolytic Activity  Human erythrocyte: Hemolysis% at 50 μm peptide LC50=0 µM

Normal (non-cancerous) Cytotoxicity  NIH-3T3: LC50>100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  l=D-Leucine; k=D-Lysine

Chiral  Mix



Physicochemical Information


Formula  C48H87N13O5

Absent amino acids  ACDEFGHIMNPQRSTVWY

Common amino acids  K

Mass  112269

Pl  11.4

Basic residues  5

Acidic residues  0

Hydrophobic residues  3

Net charge  5

Boman Index  -1299

Hydrophobicity  -67.5

Aliphatic Index  97.5

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12646578

Title  Designed antimicrobial and antitumor peptides with high selectivity

Doi 10.1074/jbc.M211204200

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.